Comerica Bank’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.93M Sell
44,154
-136,340
-76% -$8.81M 0.01% 908
2025
Q3
$12.1M Buy
180,494
+10,937
+6% +$866K 0.05% 377
2025
Q2
$14.8M Sell
169,557
-2,702
-2% -$212K 0.06% 322
2025
Q1
$11.8M Buy
172,259
+38,979
+29% +$3.18M 0.05% 356
2024
Q4
$10.4M Buy
133,280
+4,167
+3% +$309K 0.04% 406
2024
Q3
$8.66M Buy
129,113
+1,343
+1% +$110K 0.03% 466
2024
Q2
$14.5M Sell
127,770
-471
-0.4% -$59.5K 0.06% 305
2024
Q1
$17.8M Sell
128,241
-9,980
-7% -$1.25M 0.08% 252
2023
Q4
$17.2M Sell
138,221
-20,872
-13% -$2.13M 0.08% 243
2023
Q3
$14.8M Buy
+159,093
New +$17.9M 0.08% 242
2022
Q4
$14.5M Buy
132,429
+12,567
+10% +$1.38M 0.11% 168
2022
Q3
$11.9M Sell
119,862
-46
-0% -$3.9K 0.1% 196
2022
Q2
$9.67M Sell
119,908
-940
-0.8% -$85.8K 0.08% 257
2022
Q1
$15M Buy
120,848
+5,484
+5% +$600K 0.11% 157
2021
Q4
$11.7M Sell
115,364
-508
-0.4% -$73K 0.09% 227
2021
Q3
$16.4M Sell
115,872
-24,112
-17% -$3.04M 0.1% 184
2021
Q2
$17.7M Buy
139,984
+1,468
+1% +$141K 0.11% 165
2021
Q1
$14.4M Buy
138,516
+36
+0% +$3.38K 0.09% 219
2020
Q4
$12.8M Buy
138,480
+1,452
+1% +$130K 0.08% 236
2020
Q3
$14.1M Buy
137,028
+6,232
+5% +$651K 0.1% 178
2020
Q2
$13.9M Buy
130,796
+38,276
+41% +$3.42M 0.11% 171
2020
Q1
$7.69M Buy
92,520
+700
+0.8% +$43.6K 0.07% 286
2019
Q4
$5.49M Sell
91,820
-12,928
-12% -$613K 0.04% 483
2019
Q3
$3.85M Buy
104,748
+27,928
+36% +$1.09M 0.03% 655
2019
Q2
$2.83M Buy
76,820
+2,276
+3% +$71.5K 0.02% 853
2019
Q1
$2.21M Sell
74,544
-2,032
-3% -$71.4K 0.02% 1061
2018
Q4
$2.68M Buy
76,576
+1,236
+2% +$39.2K 0.02% 882
2018
Q3
$2.47M Sell
75,340
-4,044
-5% -$125K 0.02% 985
2018
Q2
$2.02M Sell
79,384
-4,724
-6% -$100K 0.01% 1259
2018
Q1
$1.53M Buy
84,108
+9,208
+12% +$136K 0.01% 1396
2017
Q4
$1.08M Buy
74,900
+1,200
+2% +$15.6K 0.01% 1594
2017
Q3
$834K Buy
73,700
+3,356
+5% +$59.3K 0.01% 1699
2017
Q2
$1.23M Buy
70,344
+5,612
+9% +$104K 0.01% 1469
2017
Q1
$1.26M Sell
64,732
-32,440
-33% -$633K 0.01% 1497
2016
Q4
$2.07M Buy
97,172
+37,992
+64% +$673K 0.02% 1175
2016
Q3
$1.23M Buy
+59,180
New +$1.32M 0.01% 1386
2016
Q2
Sell
-14,748
Closed -$246K 2094
2016
Q1
$246K Sell
14,748
-284
-2% -$4.74K ﹤0.01% 1956
2015
Q4
$299K Buy
15,032
+5,200
+53% +$108K ﹤0.01% 1866
2015
Q3
$211K Buy
+9,832
New +$219K ﹤0.01% 1949
2014
Q2
Sell
-26,332
Closed -$272K 2141
2014
Q1
$272K Buy
26,332
+112
+0.4% +$1.16K ﹤0.01% 2060
2013
Q4
$232K Buy
+26,220
New +$208K ﹤0.01% 2103

Other funds holding DXCM

Comerica Bank's DXCM Position: Q4 2025 in Review

Comerica Bank reduced its DexCom (DXCM) stake by 76% in Q4 2025, selling an estimated $8.81M and leaving 44,154 shares worth $2.93M. The position accounts for 0.01% of the portfolio, ranked #908.

Comerica Bank first reported a position in DXCM in Q4 2013 and has held it in 41 quarters since. The position peaked at $17.8M in Q1 2024. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Comerica Bank held 44,154 shares of DexCom worth $2.93M as of Q4 2025.
  • Comerica Bank sold 136,340 DexCom shares in Q4 2025, an estimated $8.81M.
  • DexCom made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #908 holding.
  • Comerica Bank first reported a position in DexCom in Q4 2013 and has held it in 41 quarters since.
  • Comerica Bank's DexCom position peaked at $17.8M in Q1 2024.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.